Free Newsletter
Better gene tech offers wave of new discoveries
Better technology has helped academic research groups finally hit their stride in finding major disease genes, according to this report in The New York Times. That became clear just days ago as several academic groups announced their separate discoveries of a group of genes that play a role in the development of diabetes. In one sudden leap, seven new genes have been added to the field of drug development work in a field that had been dominated Iceland's DeCode Genetics. The sudden onslaught of research is a sign that the promise of the human genome project is finally being realized. But researchers agree that there's still a long way to go in identifying variant genes that trigger disease and offer targets for a new generation of drugs.
- read the article from The New York Times
Related Articles:
DeCODE alleges ex-employees stole trade secrets. Report
DeCode IDs tablet problem, suspends pivotal trial. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




